EmilyPerdoncinMDFACC

PubMed

• 10 citations
  Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy.
  Kendra J Grubb, Nikoloz Shekiladze, Julianne Spencer, Emily Perdoncin, Gilbert H L Tang
  Eurointervention. 2023-07-17
• 14 citations
  Coronary Obstruction From TAVR in Native Aortic Stenosis: Development and Validation of Multivariate Prediction Model.
  Jaffar M Khan, Norihiko Kamioka, John C Lisko, Emily Perdoncin, Cheng Zhang
  JACC. Cardiovascular Interventions. 2023-02-27
• 27 citations
  Safety of same-day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID-19 era.
  Emily Perdoncin, Adam B. Greenbaum, Kendra J. Grubb, Vasilis Babaliaros, Patricia Keegan
  Catheterization and Cardiovascular Interventions. 2021-04-01

Journal Articles

• Trends in Utilization, and Comparative Safety and Effectiveness of Orbital and Rotational Atherectomy.  
  Aggarwal D, Seth M, Perdoncin E, Schreiber T, Kaki A, Alaswad K, Menees D, Sukul D, Gurm HS., JACC Cardiovascular Interventions, 1/13/2020
• Treatment of Coronary Artery Disease in Women  
  Perdoncin E, Duvernoy C., Methodist Debakey Cardiovascular Journal, 12/13/2017
• The comparative efficacy of bivalirudin is markedly attenuated by use of radial access: insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium.  
  Perdoncin E, Seth M, Dixon S, Cannon L, Khandelwal A, Riba A, David S, Wohns D, Gurm H., European Heart Journal, 9/15/2015
• Impact of worsening renal dysfunction on the comparative efficacy of bivalirudin and platelet glycoprotein IIb/IIIa inhibitors: insights from Blue Cross Blue Shield of...  
  Perdoncin E, Zhang M, Riba A, LaLonde TA, Grines CL, Gurm HS, Circulation: Cardiovascular Interventions, 12/6/2013
• Join now to see all